Clinical Trials Directory

Trials / Completed

CompletedNCT03008941

Microbiota Restoration Therapy in HIV With Repeated Low-Dose Interventions

A Phase I/II Randomized, Double-Blind, Placebo Controlled Study of Repeated Low-Dose Fecal Microbiota Restoration in HIV-Infected Subjects. The REFRESH Study

Status
Completed
Phase
Phase 1 / Phase 2
Study type
Interventional
Enrollment
30 (actual)
Sponsor
Fundacion para la Investigacion Biomedica del Hospital Universitario Ramon y Cajal · Academic / Other
Sex
All
Age
18 Years – 80 Years
Healthy volunteers
Not accepted

Summary

Altered interplay between gut mucosa and dysbiotic bacteria during HIV infection seems to contribute to chronic immune dysfunction. Manipulation of the intestinal microbiota with nutritional interventions exert limited immunologic effects, but a deep understanding of how these interventions could ameliorate gut dysbiosis and influence health among HIV-infected individuals remain unexplored. In this Phase I clinical trial, 30 HIV-infected subjects on effective ART with evidence of persistent immune dysfunction, indicated by a CD4/CD8 ratio\<1 will be included and randomized to either repeated low-dose oral fecal microbiota transplantation or placebo during 8 weeks. The primary outcome will be safety. Secondary outcomes will include changes in CD4+ T cell counts, CD8+ T cell counts, CD4/CD8 ratio, inflammatory markers, T cell activation and markers of enterocyte barrier function through week 48. Engraftment on host microbiota will be examined using Illumina sequencing of the V3-V4 16S RNA, and changes in bacterial metabolism and in the plasma metabolite fingerprint will be studied by combination of untargeted mass spectrometry and two different and complementary separation techniques in bacterial and plasma samples.

Conditions

Interventions

TypeNameDescription
BIOLOGICALFMTCapsules with fecal microbiota from healthy donors
OTHERPlaceboPlacebo capsules

Timeline

Start date
2017-01-01
Primary completion
2018-06-01
Completion
2018-10-01
First posted
2017-01-04
Last updated
2018-10-30

Locations

1 site across 1 country: Spain

Source: ClinicalTrials.gov record NCT03008941. Inclusion in this directory is not an endorsement.